News

Agios Pharmaceuticals AGIO announced that the FDA has not yet given its decision related to the company’s supplemental new drug application (sNDA) seeking approval for its only marketed drug

Kennametal Inc. KMT is poised to gain from the solid momentum in its end markets, strong product portfolio, product innovations and shareholder-friendly policies. The company remains focused on

Marvell Technology MRVL shares have lost 14.1% in the past year, underperforming the Zacks Electronics - Semiconductors industry and the Zacks Computer and Technology sector’s growth of 70.4% and

Block XYZ shares have dropped 28.2% year to date, which can be attributed to intensifying competition in the fintech industry. XYZ stock has not only underperformed its peers, such as Affirm AFRM

Tuesday, December 9, 2025Pre-market futures are flat-to-down this morning, in what is a pretty clear “risk off” sign ahead of tomorrow’s Fed decision on interest rates. Actually, the -25 basis-point

Tempus AI TEM has rallied hard in 2025, lifting expectations and scrutiny in equal measure. The setup now hinges on execution against a full slate of clinical, regulatory and commercial milestones.

After a tentative start to the month, the broader equity markets witnessed a four-day winning streak last week as the odds of the Federal Reserve lowering its benchmark borrowing rate at its final

Oklo Inc. (OKLO), a pre-revenue advanced fission developer, continues to scale toward commercial operations with sizable capital requirements. To meet this need, the company recently launched a

On Holding AG ONON has emerged as one of the standout performers in the athletic footwear and apparel space, soaring 34.5% over the past month. The company continues to gain traction with consumers

As Costco Wholesale Corporation COST prepares to unveil its first-quarter fiscal 2026 earnings results on Dec. 11, after the market closes, investors face an important decision: Should they buy the

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 9th:

FIGS FIGS: This company, which is a direct-to-consumer healthcare apparel and

Including Prologis, Inc. PLD in a portfolio appears attractive, supported by strong operating fundamentals and a favorable long-term outlook. Its industry-leading scale enhances operational

Axon Enterprise, Inc. AXON is benefiting from strong momentum in its Connected Devices segment. Healthy demand for its next-generation TASER 10 products, virtual reality training services and

CorMedix (CRMD) closed the last trading session at $11.26, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

EverQuote (EVER) closed the last trading session at $26.72, gaining 1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Royal Gold (RGLD) closed the last trading session at $198.33, gaining 7.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Tetra Tech (TTEK) closed the last trading session at $33.58, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

From a technical perspective, Alpine Income Property Trust, Inc. (PINE) is looking like an interesting pick, as it just reached a key level of support. PINE's 50-day simple moving average crossed

McGraw Hill, Inc. (MH) closed the last trading session at $16.68, gaining 51% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

AT&T Inc. T is preparing its network for upcoming winter storms to ensure customers stay connected no matter the weather.  AT&T uses its Weather Operations Center, comprising meteorologists, to

Northrop Grumman Corp. NOC recently secured a contract worth more than $200 million to manufacture the XM1211 High Explosive Proximity-fuzed round of medium caliber ammunition. The award marks an

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research